sur Fresenius SE & Co. KGaA (ETR:FRE)
Fresenius Launches €200 Million Venture Fund for Healthcare Innovation
Fresenius SE & Co. KGaA has introduced a corporate venture capital fund named Fresenius Ventures. With a planned investment exceeding €200 million over five years, it aims to support healthcare innovation by investing in early to growth-stage technologies and business models. This newly formed unit merges venture capital with expertise in medical and operational fields, providing access to clinical and scientific networks.
Michael Sen, CEO of Fresenius, emphasizes that Fresenius Ventures is critical for the strategic plan, #FutureFresenius. The initiative seeks to position the company advantageously within the healthcare ecosystem while reinforcing its innovation capabilities. Heading this project is Thomas Michael Thestrup, an experienced professional in healthcare venture capital.
Fresenius Ventures is aimed at expanding innovation networks, focusing on bio-pharmaceuticals, MedTech, and care provision. It covers areas like precision nutrition and digital care solutions, enhancing Fresenius's capital allocation strategy.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Fresenius SE & Co. KGaA